Open access
Digital cognitive phenotyping enhances risk stratification in preclinical Alzheimer's disease
Medicine
Abstract
Amyloid positivity does not reliably predict near‐term cognitive decline in preclinical Alzheimer's disease (AD). We tested whether digital cognitive phenotyping improves prognostic precision.